159 related articles for article (PubMed ID: 21669052)
1. Non-random chromosomal deletion clustering at 20q in Waldenström macroglobulinemia.
Kitahara T; Umezu T; Ando K; Kodama A; Ohyashiki JH; Ohyashiki K
Hematology; 2011 May; 16(3):139-42. PubMed ID: 21669052
[TBL] [Abstract][Full Text] [Related]
2. Deletion (20q) as the sole abnormality in Waldenström macroglobulinemia suggests distinct pathogenesis of 20q11 anomaly.
Liu YC; Miyazawa K; Sashida G; Kodama A; Ohyashiki K
Cancer Genet Cytogenet; 2006 Aug; 169(1):69-72. PubMed ID: 16875940
[TBL] [Abstract][Full Text] [Related]
3. Interstitial deletion of 20q in a patient with Waldenström macroglobulinemia following chemotherapy.
Blann MM; Velagaleti GV; Morgan DL; Martinez RE; Conlin PA; Tonk VS
Cancer Genet Cytogenet; 2002 Jan; 132(2):145-8. PubMed ID: 11850077
[TBL] [Abstract][Full Text] [Related]
4. Frequency, hematopathology, and detection of a new isodicentric variant of deletion 20q.
Smoley SA; Fink SR; Paternoster SF; Stockero KJ; Nguyen LP; Nguyen PL; Hanson CA; Dewald GW
Cancer Genet Cytogenet; 2007 Mar; 173(2):144-9. PubMed ID: 17321330
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of del(20q) in patients with hematological malignancies.
Brezinová J; Zemanová Z; Ransdorfová S; Sindelárová L; Sisková M; Neuwirtová R; Cermák J; Michalová K
Cancer Genet Cytogenet; 2005 Jul; 160(2):188-92. PubMed ID: 15993278
[TBL] [Abstract][Full Text] [Related]
6. Molecular cytogenetic analysis of Korean patients with Waldenström macroglobulinemia.
Bang SM; Seo JW; Park KU; Kim SJ; Kim K; Kim SH; Cho SR; Kim HC; Song J; Kim JS; Kim KH; Lee JH; Lee JJ; Shin MG; Suh C; Chi HS; Oh DY; Won JH; Kim HJ; Yoon SS; Lee DS;
Cancer Genet Cytogenet; 2010 Mar; 197(2):117-21. PubMed ID: 20193844
[TBL] [Abstract][Full Text] [Related]
7. Deletion(20q) as the sole abnormality in plasma cell myeloma is not associated with plasma cells as identified by cIg FISH.
White JS; Zordan A; Batzios C; Campbell LJ
Cancer Genet; 2012 Dec; 205(12):644-52. PubMed ID: 23200818
[TBL] [Abstract][Full Text] [Related]
8. Interphase FISH does not improve the detection of DEL(5q) and DEL(20q) in myelodysplastic syndromes.
Douet-Guilbert N; Herry A; LE Bris MJ; Guéganic N; Bovo C; Morel F; DE Braekeleer M
Anticancer Res; 2011 Mar; 31(3):1007-10. PubMed ID: 21498729
[TBL] [Abstract][Full Text] [Related]
9. [Clinical and molecular cytogenetic features of myeloid diseases characterized by i(20q-): a study of seven cases].
Li TY; Xue YQ; Wu YF; Pan JL; Liu DD; Gong SL
Zhonghua Yi Xue Za Zhi; 2004 May; 84(9):732-5. PubMed ID: 15200909
[TBL] [Abstract][Full Text] [Related]
10. Clinical and molecular cytogenetic studies in seven patients with myeloid diseases characterized by i(20q-).
Li T; Xue Y; Wu Y; Pan J
Br J Haematol; 2004 May; 125(3):337-42. PubMed ID: 15086414
[TBL] [Abstract][Full Text] [Related]
11. FISH studies identify the i(20q-) anomaly as a der(20)del(20)(q11q13)idic(20)(p11).
Li T; Xue Y; Wu Y; Pan J
Genes Chromosomes Cancer; 2006 Jun; 45(6):536-9. PubMed ID: 16506189
[TBL] [Abstract][Full Text] [Related]
12. Microarray CGH analyses of chromosomal 20q deletions in patients with hematopoietic malignancies.
Okada M; Suto Y; Hirai M; Shiseki M; Usami A; Okajima K; Teramura M; Mori N; Motoji T
Cancer Genet; 2012; 205(1-2):18-24. PubMed ID: 22429594
[TBL] [Abstract][Full Text] [Related]
13. Microarray CGH analysis of hematological patients with del(20q).
Wu C; Pan J; Qiu H; Xue Y; Chen S; Wu Y; zhang J; Bai S; Wang Y; Shen J; Gong Y
Int J Hematol; 2015 Nov; 102(5):617-25. PubMed ID: 26440974
[TBL] [Abstract][Full Text] [Related]
14. Refinement of the commonly deleted segment in myeloid leukemias with a del(20q).
Wang PW; Iannantuoni K; Davis EM; Espinosa R; Stoffel M; Le Beau MM
Genes Chromosomes Cancer; 1998 Feb; 21(2):75-81. PubMed ID: 9491317
[TBL] [Abstract][Full Text] [Related]
15. [Report of ten cases of hematologic malignancies with idic(20q-) and literature review].
Han YS; Xue YQ; Li TY; Zhang J; Chen SN; Pan JL; Wu YF; Wang Y; Shen J
Zhonghua Xue Ye Xue Za Zhi; 2011 Jan; 32(1):17-20. PubMed ID: 21429395
[TBL] [Abstract][Full Text] [Related]
16. Chromosome 20q deletion: a recurrent cytogenetic abnormality in patients with chronic myelogenous leukemia in remission.
Sun J; Yin CC; Cui W; Chen SS; Medeiros LJ; Lu G
Am J Clin Pathol; 2011 Mar; 135(3):391-7. PubMed ID: 21350093
[TBL] [Abstract][Full Text] [Related]
17. [Clinical and laboratory features of 13 cases of myeloid neoplasms with double del (20q)].
Bai S; Wu C; Zhang J; Chen S; Pan J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2017 Aug; 34(4):546-549. PubMed ID: 28777856
[TBL] [Abstract][Full Text] [Related]
18. Clinical and molecular cytogenetic studies in ten patients with hematological malignancies characterized by t(20;21)(q11;q11) resulted from del(20q).
Wu C; Zhang J; Bai S; Yao J; Qiu H; Xue Y; Chen S; Wu Y; Shen J; Pan J
Cancer Genet; 2016 Oct; 209(10):456-462. PubMed ID: 27810074
[TBL] [Abstract][Full Text] [Related]
19. 6q deletion discriminates Waldenström macroglobulinemia from IgM monoclonal gammopathy of undetermined significance.
Schop RF; Van Wier SA; Xu R; Ghobrial I; Ahmann GJ; Greipp PR; Kyle RA; Dispenzieri A; Lacy MQ; Rajkumar SV; Gertz MA; Fonseca R
Cancer Genet Cytogenet; 2006 Sep; 169(2):150-3. PubMed ID: 16938573
[TBL] [Abstract][Full Text] [Related]
20. [Clinical and experimental study of two cases of myelodysplastic syndromes with double isochromosome 20q- anomaly].
Gong SL; Xue YQ; Wang JM; Han FL; Xu YQ; Li JY
Zhonghua Xue Ye Xue Za Zhi; 2005 Jan; 26(1):35-8. PubMed ID: 15946507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
